Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

33.75
-0.9900-2.85%
Post-market: 33.750.00000.00%19:58 EDT
Volume:2.73M
Turnover:91.96M
Market Cap:3.75B
PE:-23.59
High:35.09
Open:34.77
Low:32.98
Close:34.74
52wk High:41.14
52wk Low:9.15
Shares:111.19M
Float Shares:109.51M
Volume Ratio:1.13
T/O Rate:2.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:15.69
PE(LYR):-22.05

Loading ...

Amylyx Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $34 From $28

THOMSON REUTERS
·
Mar 04

Stock Track | Amylyx Pharmaceuticals Plummets 5.52% Intraday Following Shelf Offering Announcement

Stock Track
·
Mar 03

Amylyx Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 03

Amylyx files automatic mixed securities shelf

TIPRANKS
·
Mar 03

Amylyx Pharmaceuticals Inc - Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 03

Amylyx reports Q4 EPS (30c), consensus (34c)

TIPRANKS
·
Mar 03

Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q4 Net Loss $0.30 a Share, vs. FactSet Est of $0.29 Loss

MT Newswires Live
·
Mar 03

Amylyx Pharmaceuticals Q4 net loss beats estimates

Reuters
·
Mar 03

Amylyx posts FY 2025 net loss of USD 144.7 million, down 52.0%

Reuters
·
Mar 03

Amylyx Pharma Q4 EPS $(0.30) Beats $(0.36) Estimate

Benzinga Earnings
·
Mar 03

Amylyx Pharmaceuticals Inc - Cash Runway Expected to Fund Operations Through Potential Avexitide Commercialization and Into 2028

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Q4 Operating Income USD -36.605 Million VS. Ibes Estimate USD -40.4 Million

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Q4 Operating Expenses USD 36.605 Million

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Inc - Phase 3 Lucidity Trial Topline Data Anticipated in Q3 2026 & Commercial Launch in 2027

THOMSON REUTERS
·
Mar 03

Press Release: Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 03

This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Benzinga_recent_news
·
Mar 03

Amylyx Pharmaceuticals Inc : Stifel Initiates Coverage With Buy Rating; Target Price $21

THOMSON REUTERS
·
Mar 03

Amylyx initiated with a Buy at Stifel

TIPRANKS
·
Mar 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 02